{"database": "lobbying", "table": "lobbying_activities", "rows": [[2471689, "3bccf137-1949-4bbc-ab83-a3eea62e4eb0", "3T", "HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES", 401105685, "STONINGTON GLOBAL LLC ON BEHALF OF NOSTRUM PHARMACEUTICALS", 2020, "third_quarter", "HCR", "1. Request to CMS/Medicaid to review drug rebate rule in regards to and AMP re-adjustment for Nitrofuratonin OS.\n2. Request to CMS to appeal baseline AMP for Nitrofuratonin OS.", "White House Office", 14000, null, 0, 1, "2020-07-17T12:33:59.850000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2471689"], "units": {}, "query_ms": 41.81161103770137, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}